Related Experiment Video

Updated: May 21, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

ABC 1 (1st International consensus guidelines for advanced breast cancer): a positive step

Kathleen I Pritchard, Berta Sousa

    Breast (Edinburgh, Scotland)
    |June 20, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: May 21, 2026

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
    03:07

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

    Published on: August 19, 2025

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

    Breast cancer research and treatment·2026

    18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Guided Stereotactic Body Radiation Therapy in Advanced Breast Cancer Patients Treated WithCyclin-Dependent Kinase 4/6 Inhibitors.

    Advances in radiation oncology·2026

    Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    In Silico Psycho-Oncology: Understanding Resilience Pathways in Breast Cancer-Determinants of Longitudinal Depression and Quality-of-Life Trajectories.

    Journal of personalized medicine·2026

    Cost-Effectiveness of a Quality of Life Predictor to Guide Psychosocial Support in Breast Cancer.

    Cancers·2026

    Fear of Cancer Recurrence and Adaptation in Early Breast Cancer Survivorship: A Latent Profile Analysis.

    Stress and health : journal of the International Society for the Investigation of Stress·2026

    Leveraging endocrine sensitivity in ER-positive DCIS: Neoadjuvant therapy and nonoperative management.

    Breast (Edinburgh, Scotland)·2026

    Biomarker-based risk stratification for predicting late recurrence and benefit of extended endocrine therapy: A secondary analysis of the IDEAL trial.

    Breast (Edinburgh, Scotland)·2026

    The clinical value of clinical treatment score post-5 years in patients with premenopausal breast cancer: a retrospective analysis of ASTRRA trial.

    Breast (Edinburgh, Scotland)·2026

    End-of-life care values and treatment preferences among Japanese breast cancer patients and families: A dyadic cross-sectional study.

    Breast (Edinburgh, Scotland)·2026

    Local treatment for HER2-positive or triple negative second ipsilateral breast cancer event: A propensity score-matched analysis of the GEC-ESTRO database.

    Breast (Edinburgh, Scotland)·2026

    Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer.

    Breast (Edinburgh, Scotland)·2026

    Unraveling the epigenetic code in cancer cell-tumor microenvironment crosstalk.

    Molecular oncology·2026

    Molecular mechanisms of therapeutic resistance in areca nut-associated oral squamous cell carcinoma: the interplay of chronic inflammation and epithelial-mesenchymal transition.

    Frontiers in oncology·2026

    Rapid normal fibroblast-tumor crosstalk promotes cancer-associated fibroblast-like activation and attenuates mitomycin C cytotoxicity in bladder cancer.

    Journal of cell communication and signaling·2026

    Deciphering the malignant synergy: metabolic reprogramming, epigenetic circuitry, and niche remodeling in osteosarcoma-macrophage crosstalk.

    Frontiers in immunology·2026

    Optimization of a Canine Colon Organoid Platform for Modeling Intestinal Injury and Mesenchymal Stem Cell-Mediated Regeneration.

    International journal of stem cells·2026

    Loss of Erbin in tubular epithelial cells sensitizes mice to acute kidney injury and aggravates renal fibrosis.

    The EMBO journal·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us